Theralase Technologies Inc. V.TLT

the clock is ticking

[riverrrow]

Private placement, joint venture, buyout, BTD, accelerated approval...  That's it, I'm going to pretend the FDA requested more data so they could give accelerated approval for Ruvidar.  Happy days, happy dreams.  GLTA.

[menoalittle]

>>  I'm going to pretend the FDA requested more data... Given that one of the big factors in the FDA's decisions on whether or not to grant BFD is durability of response, what if TLT already has a green light from the FDA ... but after getting that received (or expects to soon recieve) more positive information on durability from a patient or two that they weren't

[O12009]

And there you have it. The FDA only wants to see patients data that has completed the trial 63.The data numbers is getting better with each patient so they are waiting. AA they look at all the patients and the safety profile is taken into consideration. We should be looking at that in second quarter.

[O12009]

I guess I didn't make it clear enough when I posted this a couple days ago. The BTD hasn't been applied for yet. The FDA only wants to see the 63 patients data that has completed the trial period. We are waiting for some more patients data to be completed that will make the numbers better. The numbers are better as the trial and treatment procedures improves. This will happen in the next

[Legit62]

Where is this privy information coming from?? Was this in a news release or are you anticipating these events??? I never remember reading any of this 012009

[O12009]

Look back over the posts. Chry,gonefishing,oilminer and I tried to say the same things. Read the news release,read the posts and call IR . Nothing privy ,it is all out there. Many who are posting negative comments have already done this and are using this information to try and make the company and management look bad. Think about the reasons they are doing this and all your questions will be

[bmk211]

Get more shares cheap

[Dumbeldorfwhite]

Hahahahahahah. They re doing a pretty good job of doing that themselves. Gee I wonder why anyone would be upset with a group who's lost most people here 30%? And has continual missed projected timelines not by a little, by a country mile.

[DeathXray33]

For only an "experimental oral therapy". --------------------------------------------------------------- "Eli Lilly to buy Scorpion Therapeutics' cancer therapy for up to $2.5 billion" ---- "The company will acquire Scorpion's experimental oral therapy, STX-478, which is currently being tested in early-stage trials"

[gojotv!]

...A perfect example of why Theralase shouldn't sell out to Big Pharma... Scorpion's share price is $0.54 while Eli Lilly's is $725 with a price target in the $900 + range. Which would you rather have, the small penny stock, or shares in Canada's own Big Pharma-Tech corporation? It's not even a question...

[Alamir1111]

Eli Lilly to buy cancer drug developer Scorpion Therapeutics for up to $2.5 billionScorpion Therapeutics was founded in 2020 and it's a privatly  held company. 

[Alamir1111]

2.5 bil in tlt case would be around 15+$ sp.Eli lille can have it I wouldn't oppose that.

[bmk211]

Arnt there around 350,000,000 shares outstanding? $2,500,000,000 / 350,000,000 shares $7 per share? U.S. I don't know how a buyout works so maybe my math is wrong but I think it's only $7 per share of TLT for a 2.5 billion dollar buyout 

[Dumbeldorfwhite]

Hahahahah 2.5 billion!  TLT has no revenue ain't no way someone is offering 2.5 billion for a market cap of 40 mill company with zero revenue and no capital. This board always brings the laughs.

[Legit62]

IF and when we have BTD and AA ,yes indeed a Big phartma will pay that for bladder and other indications we have , no brainer, but as of now, i agree ,no way

[Legit62]

Meant Pharma ,bad spelling

[chry200030]

TLT is worth a lot more than 2.5 billion. At least 5 times more.(minimum).. All Aboard !

[gojotv!]

What the bashers planted on this board by BigPharma fail to tell you is that TLT doesn't just have a cure for NMIBladder Cancer. We have the patents for all Ruthenium-based PDCs derived like Ruvidar, and the Osmium-based ones, too. Then we have a lead drug that is apparently the most effective and exciting panacea since Aspirin!  It destroys cancer and viruses, creates vaccines; who knows

[wearethebest]

Now that's the way we all should look at what this company  is all about. Never mind what the ones that don't  have a click  or a clue what they are talking  about.Alittle more time not much just wait for it and we will all be happy.

[Dumbeldorfwhite]

Hahahahahahaha patents expire bub. This one I believe is 2034, so yeah doesnt matter about "future" drugs since nothing can be developed in that short of time. This board never ceases to make me laugh. 100 billion!

[wearethebest]

Maybe you should stop laughing and just smile so no one will hear you because we are not listening anyway. 

[O12009]

Great post Gojo, you are correct about freeing up congested hospitals. TLT has proven preclinicaly that when there drug is used against cancers and activated by Metoform it could be used in an outpatient procedure or even done at he doctors office. This is huge and with the proper incentives Theralase anti cancer treatment could be used so the masses can be cured. Huge very huge

[reconsider]

The fact that Dumbie is working on a Saturday is a good sign. Now, I'll take $15 per share in 1-2 years ($5B MC) without hesitation. That'd be a dream come true. Higher valuations (even higher) that realistically (is $5B in 2026 even realistic?) require decades of work... not for me. My kids can find their own investment opportunities.  For TLT to start other trials, a big fat check

[wearethebest]

Yes I agree just give it a little more time people please. We are so close to getting this out where people can use it to save lives. 

[riverrrow]

Did you just say that the company is now planning to apply for AA=accelerated approval in the second quarter as opposed to BTD?

[Eoganacht]

Thanks for the update O12009. It sounds like BTD in Q2. It's exciting to hear they are planning to apply for AA in Q2.

[kammen83]

Buying more today.

[DeathXray33]

@ > 1.646 now... Thanks & take ccare!!!

[reconsider]

8.5M shares away from being part of the board.

[riverrrow]

Unfortunately the market today isn't buying the AA application in quarter 2 story.  I would expect a big surge in buying and share price.

[reconsider]

Let's focus on BTD Q1 first. As per IR the application is still planned for Q1. 

[rollthedice10]

I would say when dealing with any government agency including FDA. putting out accurate timelines is difficult at best. I don't stress it and hang on to every little detail, when it comes, it comes. Happier life that way. I still see big rewards down the road and who knows? TLT might surprise  us soon!  But you can't rush FDA, you move at FDA speed. Period.

[chry200030]

All Aboard.. The train will be leaving the station very soon...  Boarding is in progress.....

[bmk211]

Rock and roll

[StevenBirch]

I wouldn't, not until the PP closes because people would just sell into it. I think I would even do it if the stock rose enough. Also no story means anything unless and until it comes from the company. When I say 'means anything' I mean for the stock price because there have been a lot of great contributions here that have made us all feel good about our investment.

[Sosak1]

I e-mailed this webb. to new  FDA commissioner Mr. Makary and ask him which treatment from all of those he would take if he had.      My e-mail was recieved. Muscle Invasive Bladder Cancer BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide | 2024-12-23 | Investing News | Stockhouse

[McBullish]

Is this a good idea?? I understand your intentions here by putting it on his radar but you cant predict the outcome of trying to expedite his awareness and scrutiny. Let TLT's leadership handle this the way they feel they need to. What if you inadvertently cause a problem? 

[Alamir1111]

That email might end up in a spam folder.

[Legit62]

Have to agree Alamir1111, these big wigs in FDA do not want to be receiving emails from small company shareholders,they have bigger fish to fry. If our data is as good as it is showing ,our time will come, not sure when but hopefully by 3rd quarter of the 2000s

[Dumbeldorfwhite]

In his defense can it really get much worse? We re YEARS behind on BTD 20-25 patients was all that was supposed to be needed.

[Longholder99]

Menoalittle I also wonder if AA is in play here and so TLT is making the bigger picture obvious.

[DeathXray33]

"Of all of the upcoming patent losses in biopharma, none match up to Keytruda, the industrys sales king in 2023. The immuno-oncology megablockbuster generated $25 billion in 2023 and $21.6 billion through the first nine months of 2024, demonstrating the challenge ahead for Merck as it works to grow through the drugs eventual sales decline."

[bmk211]

Brilliant!